-
1
-
-
70350501512
-
Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management
-
Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I, (2009) Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 14: 383-391.
-
(2009)
Int J Clin Oncol
, vol.14
, pp. 383-391
-
-
Mandai, M.1
Yamaguchi, K.2
Matsumura, N.3
Baba, T.4
Konishi, I.5
-
2
-
-
40749162395
-
Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress
-
Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, et al. (2008) Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14: 32-40.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 32-40
-
-
Yamaguchi, K.1
Mandai, M.2
Toyokuni, S.3
Hamanishi, J.4
Higuchi, T.5
-
3
-
-
38349041715
-
Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway
-
Liu YT, Shang D, Akatsuka S, Ohara H, Dutta KK, et al. (2007) Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway. American J Pathol 171: 1978-1988.
-
(2007)
American J Pathol
, vol.171
, pp. 1978-1988
-
-
Liu, Y.T.1
Shang, D.2
Akatsuka, S.3
Ohara, H.4
Dutta, K.K.5
-
4
-
-
84865603277
-
Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer
-
e43403
-
Akatsuka S, Yamashita Y, Ohara H, Liu YT, Izumiya M, et al. (2012) Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer. PLoS One 7 e43403.
-
(2012)
PLoS One
, vol.7
-
-
Akatsuka, S.1
Yamashita, Y.2
Ohara, H.3
Liu, Y.T.4
Izumiya, M.5
-
5
-
-
41349083323
-
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
-
Itamochi H, Kigawa J, Terakawa N, (2008) Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci 99: 653-658.
-
(2008)
Cancer Sci
, vol.99
, pp. 653-658
-
-
Itamochi, H.1
Kigawa, J.2
Terakawa, N.3
-
6
-
-
65649128979
-
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
-
Kuo KT, Mao TL, Jones S, Veras E, Ayhan A, et al. (2009) Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma. Am J Pathol174: 1597-1601.
-
(2009)
Am J Pathol
, vol.174
, pp. 1597-1601
-
-
Kuo, K.T.1
Mao, T.L.2
Jones, S.3
Veras, E.4
Ayhan, A.5
-
7
-
-
77957731999
-
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
-
Jones S, Wang TL, Shih IM, Mao TL, Nakayama K, et al. (2010) Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma. Science 330: 228-231.
-
(2010)
Science
, vol.330
, pp. 228-231
-
-
Jones, S.1
Wang, T.L.2
Shih, I.M.3
Mao, T.L.4
Nakayama, K.5
-
8
-
-
77957946398
-
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
-
Wiegand KC, Shah SP, Al-Agha OM, Zhao YJ, Tse K, et al. (2010) ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas. New Eng J Med363: 1532-1543.
-
(2010)
New Eng J Med
, vol.363
, pp. 1532-1543
-
-
Wiegand, K.C.1
Shah, S.P.2
Al-Agha, O.M.3
Zhao, Y.J.4
Tse, K.5
-
9
-
-
77950687396
-
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
-
Kuo KT, Mao TL, Chen X, Feng YJ, Nakayama K, et al. (2010) DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma. Clin Cancer Res 16: 1997-2008.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1997-2008
-
-
Kuo, K.T.1
Mao, T.L.2
Chen, X.3
Feng, Y.J.4
Nakayama, K.5
-
10
-
-
0038115834
-
Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
-
Dent J, Hall GD, Wilkinson N, Perren TJ, Richmond I, et al. (2003) Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. Brit J Cancer 88: 1578-1583.
-
(2003)
Brit J Cancer
, vol.88
, pp. 1578-1583
-
-
Dent, J.1
Hall, G.D.2
Wilkinson, N.3
Perren, T.J.4
Richmond, I.5
-
11
-
-
0033919389
-
Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas
-
Suehiro Y, Sakamoto M, Umayahara K, Iwabuchi H, Sakamoto H, et al. (2000) Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas. Oncology 59: 50-56.
-
(2000)
Oncology
, vol.59
, pp. 50-56
-
-
Suehiro, Y.1
Sakamoto, M.2
Umayahara, K.3
Iwabuchi, H.4
Sakamoto, H.5
-
12
-
-
79952712084
-
Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
-
Tan DSP, Iravani M, McCluggage WG, Lambros MBK, Milanezi F, et al. (2011) Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas. Clin Cancer Res 17: 1521-1534.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1521-1534
-
-
Tan, D.S.P.1
Iravani, M.2
McCluggage, W.G.3
Lambros, M.B.K.4
Milanezi, F.5
-
13
-
-
79961028656
-
Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
-
Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, et al. (2011) Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient. Mod Pathol 24: 1146-1155.
-
(2011)
Mod Pathol
, vol.24
, pp. 1146-1155
-
-
Yamamoto, S.1
Tsuda, H.2
Miyai, K.3
Takano, M.4
Tamai, S.5
-
14
-
-
84861333600
-
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
-
Rahman MT, Nakayama K, Rahman M, Nakayama N, Ishikawa M, et al. (2012) Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma. Cancer 118: 2846-2857.
-
(2012)
Cancer
, vol.118
, pp. 2846-2857
-
-
Rahman, M.T.1
Nakayama, K.2
Rahman, M.3
Nakayama, N.4
Ishikawa, M.5
-
15
-
-
33750033153
-
Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability
-
Yamashita Y, Tsurumi T, Mori N, Kiyono T, (2006) Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability. Pathol Int 56: 659-667.
-
(2006)
Pathol Int
, vol.56
, pp. 659-667
-
-
Yamashita, Y.1
Tsurumi, T.2
Mori, N.3
Kiyono, T.4
-
16
-
-
77649104601
-
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma
-
Hu Q, Akatsuka S, Yamashita Y, Ohara H, Nagai H, et al. (2010) Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab Invest 90: 360-373.
-
(2010)
Lab Invest
, vol.90
, pp. 360-373
-
-
Hu, Q.1
Akatsuka, S.2
Yamashita, Y.3
Ohara, H.4
Nagai, H.5
-
17
-
-
79954602254
-
XCR1 Expression and Biased V-H Gene Usage Are Distinct Feautres of Diffuse Large B-Cell Lymphoma Initially Manifesting in the Bone Marrow
-
Yamashita Y, Kajiura D, Tang L, Hasegawa Y, Kinoshita T, et al. (2011) XCR1 Expression and Biased V-H Gene Usage Are Distinct Feautres of Diffuse Large B-Cell Lymphoma Initially Manifesting in the Bone Marrow. Am J Clin Pathol 135: 556-564.
-
(2011)
Am J Clin Pathol
, vol.135
, pp. 556-564
-
-
Yamashita, Y.1
Kajiura, D.2
Tang, L.3
Hasegawa, Y.4
Kinoshita, T.5
-
18
-
-
84863398440
-
ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas
-
Yamamoto S, Tsuda H, Honda K, Takano M, Tamai S, et al. (2011) ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology 60: 1073-1083.
-
(2011)
Histopathology
, vol.60
, pp. 1073-1083
-
-
Yamamoto, S.1
Tsuda, H.2
Honda, K.3
Takano, M.4
Tamai, S.5
-
19
-
-
0034027258
-
Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study
-
Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, et al. (2000) Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study. Gynecol Oncol 77: 298-304.
-
(2000)
Gynecol Oncol
, vol.77
, pp. 298-304
-
-
Ogawa, S.1
Kaku, T.2
Amada, S.3
Kobayashi, H.4
Hirakawa, T.5
-
20
-
-
58149305448
-
Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
-
Toyokuni S, (2009) Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 100: 9-16.
-
(2009)
Cancer Sci
, vol.100
, pp. 9-16
-
-
Toyokuni, S.1
-
21
-
-
69249208791
-
The Akt kinases Isoform specificity in metabolism and cancer
-
Gonzalez E, McGraw TE, (2009) The Akt kinases Isoform specificity in metabolism and cancer. Cell Cycle 8: 2502-2508.
-
(2009)
Cell Cycle
, vol.8
, pp. 2502-2508
-
-
Gonzalez, E.1
McGraw, T.E.2
-
22
-
-
33751190974
-
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
-
Nakayama K, Nakayama N, Kurman RL, Cope L, Pohl G, et al. (2006) Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms. Cancer Biol Ther 5: 779-785.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 779-785
-
-
Nakayama, K.1
Nakayama, N.2
Kurman, R.L.3
Cope, L.4
Pohl, G.5
-
23
-
-
0035793091
-
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
-
Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, et al. (2001) Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Nat Acad Sci U.S.A. 98: 247-252.
-
(2001)
Proc Nat Acad Sci U.S.A
, vol.98
, pp. 247-252
-
-
Xiao, G.H.1
Jeffers, M.2
Bellacosa, A.3
Mitsuuchi, Y.4
Vande Woude, G.F.5
-
24
-
-
34248151416
-
Met acts on Mdm2 via mTOR to signal cell survival during development
-
Moumen A, Patane S, Porras A, Dono R, Maina F, (2007) Met acts on Mdm2 via mTOR to signal cell survival during development. Development 134: 1443-1451.
-
(2007)
Development
, vol.134
, pp. 1443-1451
-
-
Moumen, A.1
Patane, S.2
Porras, A.3
Dono, R.4
Maina, F.5
-
25
-
-
68849093989
-
Tumour suppression by p53: the importance of apoptosis and cellular senescence
-
Zuckerman V, Wolyniec K, Sionov RV, Haupt S, Haupt Y, (2009) Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol 219: 3-15.
-
(2009)
J Pathol
, vol.219
, pp. 3-15
-
-
Zuckerman, V.1
Wolyniec, K.2
Sionov, R.V.3
Haupt, S.4
Haupt, Y.5
-
26
-
-
0024523622
-
Tyrosine Kinase Receptor Indistinguishable from the C-Met Protein
-
Giordano S, Ponzetto C, Direnzo MF, Cooper CS, Comoglio PM, (1989) Tyrosine Kinase Receptor Indistinguishable from the C-Met Protein. Nature 339: 155-156.
-
(1989)
Nature
, vol.339
, pp. 155-156
-
-
Giordano, S.1
Ponzetto, C.2
Direnzo, M.F.3
Cooper, C.S.4
Comoglio, P.M.5
-
27
-
-
0025075114
-
Gene Amplification in Gastric and Esophageal Adenocarcinomas
-
Houldsworth J, Cordoncardo C, Ladanyi M, Kelsen DP, Chaganti RSK, (1990) Gene Amplification in Gastric and Esophageal Adenocarcinomas. Cancer Res 50: 6417-6422.
-
(1990)
Cancer Res
, vol.50
, pp. 6417-6422
-
-
Houldsworth, J.1
Cordoncardo, C.2
Ladanyi, M.3
Kelsen, D.P.4
Chaganti, R.S.K.5
-
28
-
-
0027055114
-
Frequent Amplification of the C-Met Gene in Scirrhous Type Stomach-Cancer
-
Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, et al. (1992) Frequent Amplification of the C-Met Gene in Scirrhous Type Stomach-Cancer. Biochem Biophys Res Comm 189: 227-232.
-
(1992)
Biochem Biophys Res Comm
, vol.189
, pp. 227-232
-
-
Kuniyasu, H.1
Yasui, W.2
Kitadai, Y.3
Yokozaki, H.4
Ito, H.5
-
29
-
-
30944452172
-
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma
-
Miller CT, Lin L, Casper AM, Lim J, Thomas DG, et al. (2006) Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25: 409-418.
-
(2006)
Oncogene
, vol.25
, pp. 409-418
-
-
Miller, C.T.1
Lin, L.2
Casper, A.M.3
Lim, J.4
Thomas, D.G.5
-
30
-
-
63849163410
-
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients
-
Cappuzzo F, Marchetti A, Skokan M, Rossi E, Gajapathy S, et al. (2009) Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients. J Clin Oncol 27: 1667-1674.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1667-1674
-
-
Cappuzzo, F.1
Marchetti, A.2
Skokan, M.3
Rossi, E.4
Gajapathy, S.5
-
31
-
-
73649102105
-
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
-
Turke AB, Zejnullahu K, Wu YL, Song Y, Dias-Santagata D, et al. (2010) Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC. Cancer Cell 17: 77-88.
-
(2010)
Cancer Cell
, vol.17
, pp. 77-88
-
-
Turke, A.B.1
Zejnullahu, K.2
Wu, Y.L.3
Song, Y.4
Dias-Santagata, D.5
-
32
-
-
0028946604
-
Overexpression and Amplification of the Met/Hgf Receptor Gene During the Progression of Colorectal-Cancer
-
Direnzo MF, Olivero M, Giacomini A, Porte H, Chastre E, et al. (1995) Overexpression and Amplification of the Met/Hgf Receptor Gene During the Progression of Colorectal-Cancer. Clin Cancer Res 1: 147-154.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 147-154
-
-
Direnzo, M.F.1
Olivero, M.2
Giacomini, A.3
Porte, H.4
Chastre, E.5
-
33
-
-
66149135285
-
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
-
Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, et al. (2009) The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Res 69: 3021-3031.
-
(2009)
Cancer Res
, vol.69
, pp. 3021-3031
-
-
Seiwert, T.Y.1
Jagadeeswaran, R.2
Faoro, L.3
Janamanchi, V.4
Nallasura, V.5
-
34
-
-
0033135820
-
The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas
-
Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, et al. (1999) The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85: 1894-1902.
-
(1999)
Cancer
, vol.85
, pp. 1894-1902
-
-
Nakajima, M.1
Sawada, H.2
Yamada, Y.3
Watanabe, A.4
Tatsumi, M.5
-
35
-
-
21344438897
-
Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers
-
Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, et al. (2005) Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. J Pathol 206: 356-365.
-
(2005)
J Pathol
, vol.206
, pp. 356-365
-
-
Nakazawa, K.1
Dobashi, Y.2
Suzuki, S.3
Fujii, H.4
Takeda, Y.5
-
36
-
-
33847746580
-
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
-
Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, et al. (2007) c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 67: 1670-1679.
-
(2007)
Cancer Res
, vol.67
, pp. 1670-1679
-
-
Sawada, K.1
Radjabi, A.R.2
Shinomiya, N.3
Kistner, E.4
Kenny, H.5
-
37
-
-
0032523074
-
Expression of c-met is a strong independent prognostic factor in breast carcinoma
-
Ghoussoub RAD, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, et al. (1998) Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 82: 1513-1520.
-
(1998)
Cancer
, vol.82
, pp. 1513-1520
-
-
Ghoussoub, R.A.D.1
Dillon, D.A.2
D'Aquila, T.3
Rimm, E.B.4
Fearon, E.R.5
-
38
-
-
33745220780
-
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
-
Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor VM, et al. (2006) Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest116: 1582-1595.
-
(2006)
J Clin Invest
, vol.116
, pp. 1582-1595
-
-
Kaposi-Novak, P.1
Lee, J.S.2
Gomez-Quiroz, L.3
Coulouarn, C.4
Factor, V.M.5
-
39
-
-
33646492630
-
Effect of c-Met expression on survival in head and neck squamous cell carcinoma
-
Lo Muzio L, Farina A, Rubini C, Coccia E, Capogreco M, et al. (2006) Effect of c-Met expression on survival in head and neck squamous cell carcinoma. Tumor Biol 27: 115-121.
-
(2006)
Tumor Biol
, vol.27
, pp. 115-121
-
-
Lo Muzio, L.1
Farina, A.2
Rubini, C.3
Coccia, E.4
Capogreco, M.5
-
40
-
-
33144462553
-
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
-
Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, et al. (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Nat Acad Sci U.S.A. 103: 2316-2321.
-
(2006)
Proc Nat Acad Sci U.S.A
, vol.103
, pp. 2316-2321
-
-
Smolen, G.A.1
Sordella, R.2
Muir, B.3
Mohapatra, G.4
Barmettler, A.5
-
41
-
-
56249137901
-
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
-
Bachleitner-Hofmann T, Sun MY, Chen CT, Tang L, Song L, et al. (2008) HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells. Mol Cancer Ther 7: 3499-3508.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 3499-3508
-
-
Bachleitner-Hofmann, T.1
Sun, M.Y.2
Chen, C.T.3
Tang, L.4
Song, L.5
-
42
-
-
10744228765
-
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo
-
Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, et al. (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 63: 7345-7355.
-
(2003)
Cancer Res
, vol.63
, pp. 7345-7355
-
-
Christensen, J.G.1
Schreck, R.2
Burrows, J.3
Kuruganti, P.4
Chan, E.5
-
43
-
-
51749095291
-
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion
-
Koon EC, Ma PC, Salgia R, Welch WR, Christensen JG, et al. (2008) Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer 18: 976-984.
-
(2008)
Int J Gynecol Cancer
, vol.18
, pp. 976-984
-
-
Koon, E.C.1
Ma, P.C.2
Salgia, R.3
Welch, W.R.4
Christensen, J.G.5
|